Skip to main content

NIPT Market Expected to Reach $10.82 Billion By 2030

 

Technological advancements in the healthcare industry have always played a crucial role in its overall development. The recent advancements in the life science industry, such as wearable healthcare devices, sequencing technologies, regenerative medicine, and genomic technologies, supported by breakthroughs in the field of genome sequencing, and molecular research, have opened up new and promising pathways to combat genetic diseases and reduce the overall global economic burden. Several conglomerate companies and start-ups, including Illumina, Inc., F. Hoffmann-La Roche AG, and Diagnomics Inc. based in the developed countries, such as the U.S., the U.K., Germany, China, France, and Canada have been making significant investments in the fields of life sciences to develop promising gene sequencing-based non-invasive diagnostic procedures to promote global health. Among the innumerable advancements witnessed by the industry, non-invasive prenatal testing (NIPT) today stands as one of the most distinctive technologies in curbing the concerns related to genetic diseases.

Prenatal testing is undertaken before the birth of the child to identify chromosomal abnormalities in the fetus, which are at high risk of developing such abnormalities. Prenatal testing comes under the purview of antenatal care”. It involves various techniques and methods which can detect numerous genetic disorders present in the fetus and health problems in pregnant women. These genetic disorders, many of which are inherited, are dominant X-linked autosomal recessive disorders, which are easy to be detected in both conditions: prior to pregnancy and during pregnancy. It has been estimated that at the maternal age of 30 years, the risk of chromosomal abnormality increases approximately to 1/385 live birth rate.

As per BIS Research analysis, the global NIPT market was valued $2.18 billion in 2019, and is expected to reach $10.82 billion by 2030. The growth is attributed to the increasing reimbursement policies and insurance coverage across the globe. Further, the continued significant investments for genome sequencing by healthcare companies to meet the industry demand and growing incidence of genetic disorders are the prominent factors propelling the growth of the global NIPT market. 


Comments

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...
1 comment
Read more

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...
1 comment
Read more